Drug Target Review

🔊 Latest news!   🧬The real-time capture of transcription complex formation Researchers at The Rockefeller University and the New York Structural Biology Center have obtained images with a previously unseen level of detail, demonstrating how RNA polymerase opens the transcription bubble. Click on the link in the comments to read more👇 #transcription #RNAP #imaging

🩺🔍Elevate your research on screening methods! Discover inside this report with BellBrook Labs how screening is revolutionising the detection and diagnosis of prevalent conditions like cancer and metabolic diseases. Highlights: 🔬Expert insights from leading professionals 🔬Innovative 2-phase physiochemical system for early prostate cancer detection 🔬Promising antimicrobial agents against Leishmania donovani identified through hit-to-lead optimisation 🔗 Link to report: https://bit.ly/3yZq1db #cancerscreening #metabolicdiseases #prostatecancer

📈 We have officially reached halfway through 2024! Currently, what is the largest trend in drug discovery? 📈 #drugdiscovery #AI #trend

💻 Join our webinar with Eurofins DiscoverX on 18th September at 16:00 BST! 🌐 The value of GPCR cell-based assays in drug discovery Speaker Terry Kenakin will share more about: ✅ Key differences in binding versus functional assay formats and the theoretical limitations of animal orthologue assays ✅ How the study of GPCR agonism has changed over the past 50 years ✅ How cell-based assay “volume control” (testing in systems of varying sensitivity) can reveal complex behaviours of drug candidates ✅ Case studies highlighting the application of cell-based assay data to understand drug candidate actions that affect clinical profiles Register now: https://bit.ly/3XS6Vjo #Assay #HitToLead #DrugDiscovery

🔊 Weekly round-up! 💊 SRP-001: redefining pain treatment with a safer, non-opioid analgesic This Q&A with Dr Hernan A Bazan, CEO and Co-founder of South Rampart Pharma, Inc., discusses the potential merits of novel non-opioid analgesic SPR-001, which is Phase II-ready for acute and neuropathic pain and migraines. Its benefits mean it is poised to disrupt the $87 billion pain management market and address significant clinical and societal unmet needs. 👩🔬 Women in STEM with Morgane Rousselot We had the privilege of speaking to Morgane Rousselot, co-founder and CEO of SeaBeLife Biotech for our Women in STEM series. With a strong scientific background and over two decades of entrepreneurial experience in the biotechnology field, she leads the company with a team-focused approach and intellectual rigor. 🦠 Developing a globally-applicable HIV cure Led by Weill Cornell Medicine, a new assay has been developed which enables the detailing of intact proviral genomes of under-studied HIV strains. 🧬Studying the epigenetic profile of beta cells in insulinoma Researchers at Universitat Pompeu Fabra found that tumour beta cells lose their repression marks and express elevated levels of oncogenes. Click on the links in the comments to read more! 👇 #drugdiscovery #lifescience #drugtargets

📢 Don't miss our upcoming webinar on 29 JULY 2024 at 3PM BST - a must-attend event for anyone in the field of oncology and medical research! WEBINAR: Immunotherapy Advancements: Transforming Cancer Treatment Expert speakers include: 🧬 Keir Loiacono, Esq., Chief Executive Officer of BlueSphere Bio 🧬 Philipp Spycher, PhD, Co-Founder & Chief Scientific Officer of Araris Biotech Learn from the best in the field and discover how these advancements are changing the landscape of cancer treatment. 🔗 Secure your spot now - Register for FREE! https://bit.ly/3ypxsK6 #CancerTreatment #Immunotherapy #Webinar #Oncology #MedicalResearch

🔊 Latest article! 👩🔬Women in STEM with Morgane Rousselot We had the privilege of speaking to Morgane Rousselot, co-founder and CEO of SeaBeLife Biotech for our Women in STEM series. With a strong scientific background and over two decades of entrepreneurial experience in the biotechnology field, she leads the company with a team-focused approach and intellectual rigor. Click the link in the comments to read more! 👇 #women #STEM #inspiring

🎙️ New Podcast Alert! 🎙️ 🧬Introducing our latest episode with Molecular Devices: "Small Molecules for Regenerative Medicine." Discover up-to-date insights as we explore how advancements in stem cell biology are paving the way for innovative therapeutics in regenerative medicine, going beyond traditional cell therapy. This episode focuses on tackling degenerative muscle diseases with it's many solutions. Join our special guests: 🌟 Frank Gleeson, CEO and co-founder of Satellos Bioscience Inc. 🌟 Dr. Michael Rudnicki, co-founder and Chief Discovery Officer at Satellos 🔊Tune in now for an enlightening conversation: https://bit.ly/4cuiUYp #regenerativemedicine #stemcells #podcast

📢 Are you ready for this week's news, insights and resources? ✅ What can scientists do with LLMs with Dr Dr Raminderpal Singh ✅ Changing the paradigm of drug discovery processes with AI with Fabrice Chouraqui ✅ Novel inhibitor developed to combat HER2-positive breast cancer ✅ Elucidating the loss of mobility caused by LGMD2B 💻 Don't forget to sign up for our editorial webinar focusing on immunotherapy! #CancerResearch #Immunotherapy #DrugDiscovery #AI

AD | SAFIRE - Eurofins Discovery’s Precision AI for Faster & Smarter Drug Discovery In the complex landscape of drug discovery, where fate of a potential drug hinges on its ADMET properties, world-class machine learning models are essential. Our team of top data scientists, medicinal chemists, and ML engineers have collaborated to develop SAFIRE (Suite of ADMET Predictions For In Silico Refinement and Evaluation). SAFIRE delivers big benefits: •           Fast and accurate predictions •           14 state-of-the-art ADMET models and more •           User-friendly web-based interface •           Robust scoring metrics Try SAFIRE for FREE at https://lnkd.in/enkpxPCZ Learn more about SAFIRE by registering to view our free webinar on-demand: https://lnkd.in/gNdJp9zB #drugdiscovery #machinelearning